Association of moderately abnormal behavior and administered neuraminidase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of moderately abnormal behavior and administered neuraminidase inhibitors

Published:2020-02-29 Issue:1 Volume:14 Page:50-53
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Sugawara Tamie¹,Ohkusa Yasushi¹,Taniguchi Kiyosu²,Miyazaki Chiaki³,Momoi Mariko Y.⁴,Okabe Nobuhiko⁵

Affiliation:

1. Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.

2. National Hospital Organization Mie National Hospital, Mie, Japan.

3. Fukuoka Welfare Center for the Disabled, Fukuoka, Japan.

4. Ryoumou Seishi Ryogoen for the Severely Disabled, Gunma, Japan.

5. Kawasaki City Institute for Public Health, Kawasaki, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/14/1/14_2019.01091/_pdf

Reference14 articles.

1. 1. Kashiwagi S, Yoshida S, Yamaguchi H, Niwa S, Mitsui N, Tanigawa M, Shiosakai K, Yamanouchi N, Shiozawa T, Yamaguchi F. Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance. Int J Antimicrob Agents. 2012; 40:381-388.

2. 2. Nakano T, Okumura A, Tanabe T, Niwa S, Fukushima M, Yonemochi R, Eda H, Tsutsumi H. Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance. Scand J Infect Dis. 2013; 45:469-477.

3. 3. Nakamura Y, Sugawara T, Ohkusa Y, Taniguchi K, Miyazaki C, Momoi M, Okabe N. Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013. J Infect Chemother. 2014; 20:789-793.

4. 4. Toovey S, Prinssen EP, Rayner CR, Thakrar BT, Dutkowski R, Koerner A, Chu T, Sirzen-Zelenskaya A, Britschgi M, Bansod S, Donner B. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: An updated review. Adv Ther. 2012; 29:826-848.

5. 5. Hoffman KB, Demakas A, Erdman CB, Dimbil M, Doraiswamy PM. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012. BMJ. 2013; 347:f4656.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3